Microbiology Reader
Equipment to run microbiology work automatically

Growth Curves of any strain.
Microbiological calculations.

Microbiology Home
Microbioloy Reader
Growth Curves
Photo Album
Microorganisms
Software
Download
Purchasing
Contact Us

Scientific Publications - Work Done by Microbiology Reader Bioscreen C

 

Avian Pathology, Volume 31, Number 2, April 01, 2002, p. 183-191

Serum resistance  of Pasteurella multocida  in avian and porcine sera,  and comparative virulence investigations  of selected serum-sensitive  and resistant strains in chickens

Amandus P. Muhairwa, Jens P. Christensen, Magne Bisgaard

 

ABSTRACT

Growth in serum of Pasteurella multocida and related species in chicken, turkey, duck and pig sera were compared, and selected serum-resistant and serum-sensitive strains were inoculated into 18-week-old layers. Eighty-seven field strains of Pasteurella spp. and nine reference strains representing different clones defined by restriction endonuclease analysis (REA) profiles were used in the study. Serum activity was measured by changes in the optical density (OD) of the serum after inoculation and incubation at 41°C for chicken, turkey and duck serum and 39°C for pig serum. Serum activity was measured by comparison with previously determined serum-resistant (P-1059) and serum-sensitive (CU vaccine) strains, and classified into highly serum-resistant, moderately serum-resistant and serum-sensitive. Strains of the same REA type were found to have identical growth curves and the same maximum OD values when tested in serum from the same host species. Turkey serum was shown to be less inhibitory to a wide range of P. multocida strains than chicken, duck and pig sera. Serum-resistant strains were demonstrated among avian as well as mammalian strains. Among the avian strains, the proportion of serum-resistant strains was higher in outbreak strains than in strains from apparently healthy carriers. Removal of the capsule from selected strains by hyaluronidase treatment failed to change the serum activity. The most severe lesions in experimentally infected chickens were produced by a serum-resistant strain; however, lesions were also found in chickens infected by serum-sensitive strains, indicating the involvement of multiple factors in the virulence of P. multocida. Further investigations on serum resistance are indicated in order to relate other host and bacterial factors responsible for the development of fowl cholera.

 

Introduction

Attempts to understand the determinants of viru­lence factors of Pasteurella multocida obtained from fowl cholera have met with limited success. The role of the capsule as a virulence-contributin g factor in fowl cholera has been recognized for a long time; however, other factors such as serum resistance, which also seem to be important in virulence (Hansen & Hirsh, 1989; Morishita et al., 1990), have not received comparable attention. Correlation between serum resistance and virulence in animals has been demonstrated for some strains of P. multocida (Lee et al., 1988a; Diallo & Frost, 2000) and other Gram-negative bacteria, for exam­ple Escherichia coli (Ellis et al., 1988) and Yersinia ruckeri (Davies, 1991). Lee et al. (1988a) demon­strated that highly virulent strains of P. multocida obtained from turkey were resistant to turkey serum, reaching a higher optical density (OD) value than the avirulent strains. Subsequent investigations by Morishita et al. (1990) showed the presence of serum-resistant virulent P. multocida strains among isolates obtained from wild animals in turkey premises. In the same study, less virulent strains were found to have a lower survival rate in turkey serum. Serum-resistant strains are thus assumed to have a survival advantage in the blood system of the host, which allows them to proliferate and produce disease (Taylor, 1983).

Severity and incidence of P. multocida infection is known to vary considerably among different species of birds (Matsumoto et al., 1991; Rimler & Glisson, 1997; Petersen et al., 2001). Turkeys are considered to be the most susceptible, together with ducks, while chickens seem to be the least susceptible of the three. Comparison of the growth of similar strains in sera from different avian hosts may provide more insights into the susceptibility of different avian species to P. multocida infection. Knowledge of the behaviour in avian sera of strains from hosts supposed to be of importance in the epidemiology of fowl cholera may also be of help in the identification of hosts of real importance.

The present study aimed to compare serum resistance of diverse P. multocida strains and related species in the sera from chickens, turkeys, ducks and pigs. The results were subsequently correlated with genotype and source of the strain. Correlation between serum activity, virulence, and persistence in trachea and cloaca was investigated in experi­mentally infected chickens.

Materials and Methods

Serum resistance assays

Bacteria. A total of 87 field strains of Pasteurella spp. and nine reference strains (Table 1) were investigated for growth in sera obtained from chickens, ducks, turkeys and pigs. Field strains included isolates from free-ranging chickens and ducks in Tanzania, and dogs and cats kept in contact with them (Muhairwa et al., 2001a), and outbreak and carrier strains obtained from commercial poultry flocks in Denmark (Muhairwa et al., 2000). After initial isolation from the hosts, the strains were stored at –80°C and were subcultured once for use in serum resistance experiment. The selected field strains represented clones defined by restriction endonuclease analysis (REA) patterns and ribotypes as described previously (Muhairwa et al., 2001b). Reference strains included serum-sensitive strains, E. coli (K12) (Diallo & Frost, 2000), P. multocida (CU vaccine strain) and a serum-resistant strain of P. multocida (P-1059) (Hansen & Hirsh, 1989). Other reference strains included an outbreak clone (P-40605) from wild birds in Denmark (Christensen et al., 1998), and the type strains of P. multocida ssp. multocida (NCTC 10322T), P. multocida ssp. septica (NCTC 11995T), P. multocida ssp. gallicida (HIM 830–7T), Pasteurella gallinarum (ATCC 13361T), Pasteurella canis (NCTC 11621T) and Pasteurella stomatis (HIM 657T).

Collection of serum. Apparently healthy broilers (5 weeks old), ducks (7 weeks old) and turkeys (20 weeks old) from farms with no previous history of P. multocida infection were used for blood collection. The collected blood was allowed to clot at room temperature for 1 h, then cooled to 4°C for 1 h followed by centrifugation and filter sterilization (0.2 ml). Pooled pig serum was obtained from P. multocida-free pigs kept at the Danish Veterinary Laboratory, Copenhagen, Denmark. All sera were stored at –20°C, and each time before use they were thawed and filter sterilized.

Measurement of serum activity of Pasteurella strains. Preliminary assays were conducted using serum-sensitive and serum-resistant reference strains to determine the concentration of bacteria required for inoculation into the sera. The growth of these strains in serum from individual birds was also examined. Strains of the same REA type and recovered from animals of the same species were compared to determine the correlation between serum activity and the genotype.

Lytic action of complement in chicken, duck, turkey and pig sera was monitored by inoculation of 10 ml test organisms containing approx­imately 106 colony forming units (CFU)/ml into 200 ml normal serum, heat-inactivated serum (56°C for 30 min), and brain-heart infusion (BHI) broth in a microtitre plate. Duplicate suspensions of each strain were subsequently placed in a Bioscreen microplate turbidometer (Labsystems, Finland), and incubated overnight at 41°C for chicken, duck and turkey serum, and at 39°C for porcine serum. BHI broth growth controls were performed at 41°C for avian sera and at 39°C for porcine serum. Bacterial lysis and growth were monitored by changes in turbidity every 10 min and recorded automatically in BioLink (Labsystems Computer software). The data were subsequently trans­ferred into the Excel program (Microsoft Corporation, 1999) and growth curves were analysed. The experiment was repeated twice on separate days to test the reproducibility of the results.

The strains were classified into serum-resistant and serum-sensitive by comparison with the reference serum-resistant strain P. multocida (P-1059) and serum-sensitive CU vaccine strain (Hansen & Hirsh, 1989). Highly serum-resistant strains included strains that had OD values equal to or above that of strain P-1059, and moderate serum­resistant strains had OD values below that of P-1059 but above that of CU strain. The strains with ODs equal to or below that of the CU strain were considered to be serum-sensitive (Table 2).

 

Effect of the capsule on serum resistance.

Five serum-sensitive strains and five serum-resistant strains were treated with hyaluronidase to study the effect of the capsule on serum resistance. Two previously serotyped strains P-1059 (A:3) and P 40506 (A:3) were among the serum-resistant strains used as reference for capsulated strains. The capsular material was removed from encapsulated strains by growth in BHI broth containing 100 U/ml hyaluronidase (Sigma Chemical Co.) (Poermadjaja & Frost, 2000). The presence of a capsule in the normal and digested bacteria was demonstrated by staining with 1% crystal violet (Sigma) as described by Jasmin (1945). After hyaluronidase treatment, the serum activities of the strains were determined as already described.

 

Experimental infection of chickens

Chickens. Fifty 18-week-old layers from a P. multocida-free flock were used for experimental infection. Prior to the experiment, the trachea and cloacae of all chickens were swabbed, and examination for the presence of P. multocida was examined by mouse passage as described by Muhairwa et al. (2000). Briefly, the swabs were transferred into BHI and vortexed before 0.25 ml was injected intraperitoneally into Balb Cj mice raised at the department. Chickens were divided into five groups of 10 chickens, four groups were inoculated with different strains of P. multocida (Table 3), while the control group was inoculated with sterile BHI broth.

 

Selection of strains.

Four P. multocida ssp. multocida strains were selected for experimental infection of chickens (Table 3). These included two serum-resistant strains, one obtained from a cat (MC 6BA) while the other represented a clone (P-40605) obtained from fowl cholera in wild birds (Christensen et al., 1998), and two serum­sensitive strains obtained from a duck (Mamo 2) and a cat (KC 14Hpg). All stock strains had been stored at –80°C since initial isolation.

 

Preparation of cultures for inoculation.

Before each experiment, each strain was thawed and plated on 5% calf blood agar (Tryptose blood agar Base; Difco Laboratories, Michigan, USA) and incubated aerobically at 37°C overnight to check for purity. Three to five colonies were then inoculated into 10 ml BHI broth and incubated overnight at 37°C with moderate shaking. The overnight broth was diluted 1 : 50 in BHI broth preheated to 41°C and then incubated aerobically at 37°C with moderate shaking to the mid-exponential phase. When OD410 corresponding to 2 ´ 108 was reached, 1 ml was diluted serially in 9 ml broth to a final concentration of 2 ´ 104 CFU/ml. An estimate of the bacterial count in the inoculum was calculated from the average of duplicate dilutions of each strain. The chickens in each group were separately inoculated intratracheally with 0.5 ml containing approx­imately 104 CFU respective strain. Control birds were inoculated intratracheally with 0.5 ml sterile BHI.

 

Parameters measured.

Twenty-four hours after inoculation, five randomly selected chickens in each group were killed by decapitation and a postmortem examination performed to assess the development of the lesions. The remaining birds were screened for P. multocida in the trachea and cloaca at 24 h, 7 days and 14 days after infection (Table 3). Detection of P. multocida in the trachea and cloaca was by mouse inoculation as already described. At the end of the experiment, the remaining birds were also killed by decapitation and subjected to postmortem examination.

 

Statistical analysis

The chi-square test was used to compare the proportions of serum­resistant and serum-sensitive P. multocida strains in chicken, duck, turkey and pig sera.

 

 

 

Table 1. Serum activity observed for different Pasteurella species in the serum from chickens, ducks, turkeys and pigs

 

 

 

Results

Serum resistance study

Preliminary serum activity studies.

No variation in the growth pattern and maximum OD values was observed when the same strain was inoculated in sera from different birds of the same species. Consequently, sera of each species were pooled together for use in the major study. Strains of identical REA types were found to have identical growth curves and the same maximum OD values when cultured in serum from the same host species. Different concentrations of inocula attempted before the major experiment showed that a final concentration of about 104CFU/ml in the sera and BHI broth resulted in a smooth growth curve. Very low doses resulted in a prolonged lag phase.

 

Growth of the Pasteurella strains in sera from different animals.

In BHI broth and heat-treated sera from chickens, ducks, turkeys and pigs, all Pasteurella spp. strains were able to grow as indicated by changes in the turbidity of samples. No Pasteurella strain was completely killed in unhea­ted chicken and pig serum. However, one P. multocida ssp. multocida strain and one P. canis strain were killed in duck serum and two P. canis strains were killed in turkey serum. Maximum OD values of investigated strains ranged from 0.5 to 0.7 in BHI broth, from 0.3 to 2.0 in chicken serum, from 0.2 to 2.0 in duck serum, from 0.1 to 2.0 in turkey serum, and from 0.2 to 1.2 in pig serum (Table 2). Heat-inactivated sera resulted in a shorter lag phase and slightly higher maximum OD values than those of unheated sera. The serum-sensitive reference strain E. coli K12 demonstrated a short phase of growth followed by inhibition of growth in chicken serum and was completely inhibited in sera from other animals. However, this strain repro­duced in all heat-inactivated tested sera and BHI broth, indicating the presence of complement bactericidal effect in the non-inactivated sera tested. The serum-sensitive reference strain of P. multo­cida, the CU vaccine strain, grew in all test sera, but the maximum OD values obtained were lower than those of the reference serum-resistant strain P-1059 (Table 2).

 

 

Table 2. Maximum OD° values of representative Pasteurella strains showing serum-resistant, moderately serum-resistant, and serum sensitive strains in chicken, duclk turkey and porcine sera.
Comparative OD values of the strains in BHP' broth are also shown.

 

 

Significance of the capsule.

Digestion of the capsule by treatment with hyaluronidase was dem­onstrated from strains P-1059 and P-40605. Typical capsules were not demonstrated in any of the remaining eight strains either before or after hyaluronidase treatment; however, there was no change in the maximum OD values of all 10 strains tested.

 

Statistical analysis

Sixty-seven out of 80 P. multocida strains were found to be serum resistant (highly or moderately resistant) in turkey serum (Table 1), which was statistically significantly higher (P < 0.001) than the proportion of the serum-sensitive strains when the same strains were grown in sera from chicken (10/80), duck (15/80) and pig (13/80). Considered together, the remaining Pasteurella species showed no statistically significant (P > 0.05) difference in the proportion of serum-resistant to serum-sensitive strains in chicken, turkey and duck sera (Table 1). However, these strains were more sensitive to pig serum (P < 0.05).

 

Experimental infection results

Pathological findings. In the group inoculated with the serum-resistant strain (MC 6BA), one chicken was found dead after 24 h, while no mortality was observed in the remaining groups (Table 3). Varia­tions in the severity of pathological lesions were evident among the chickens infected with different strains both after 24 h and after 2 weeks.

 

Lesions observed in chickens inoculated with serum-resistant strains.

Twenty-four hours after infection, the chickens infected with serum-resist­ant strains had congestion in the trachea, and three out of five chickens infected with strain P-40506 had haemorrhagic tracheitis. The feline isolate, MC 6BA, caused unilateral fibrinous pleuritis and airsacculitis in all chickens. Two chickens had hepatomegaly with diffuse multifocal greyish foci on the liver surface. Enlarged spleens with multi­focal grey lesions were also observed. P. multocida was re-isolated from the spleens of two chickens although not from the chicken that was found dead. Strain P-40605 caused more severe lung lesions, characterized by unilateral fibrinous pleuropneumo­nia. The livers of four chickens were pale, enlarged and friable, and P. multocida was re-isolated from the spleens of all five. Multifocal grey lesions were observed on the spleen of one chicken.

In chickens killed after 2 weeks, those inoculated with strain MC 6BA strain had unilateral mild pleuritis, which was localized on the caudal margin of the lung lobes. One bird among the chickens infected with strain P-40605 was on sternal recum­bency. All these chickens had unilateral lesions in the lungs, which included oedema and fibrinous pleuritis. The recumbent chicken had unilateral diffuse lung necrosis, and P. multocida was re­isolated from its spleen.

 

Lesions in chickens infected with serum-sensitive strains.

In chickens killed after 24 h, strain KC 14Hpg caused fibrinopurulent pleuritis and air­sacculitis, which were unilateral in two chickens and bilateral in the remaining three chickens. Comparatively, the lesions were more severe than those of strain MC 6BA but less severe than those of strain P-40605. Liver and spleen enlargement were conspicuous in one chicken, which also had multifocal grey lesions on the spleen. P. multocida was re-isolated from the spleen of two of the five chickens infected with strain KC 14Hpg. Strain Mamo 2 caused the least severe lesions, which included marginal pleuritis in the caudal lobes of the lungs in all infected birds. P. multocida was isolated from the spleen of one chicken.

Chickens killed after 2 weeks in groups infected with strain KC 14Hpg had fibrinous pleuritis in all birds and unilateral diffuse necrosis of the lungs in two chickens. Slight oedema was observed in the lungs of chickens infected with strain Mamo 2. P. multocida was not re-isolated from the spleen in either group.

 

Carriers of different strains following infection.

With the exception of the group infected with strain MC 6BA, P. multocida was re-isolated from at least one chicken in the other groups (Table 3). However, only strain P-40605 persisted in the trachea of chickens until the end of the experiment. Only one bird that was in sternal recumbency for 2 weeks after infection had P. multocida in both the trachea and cloaca. All others samples were negative for P. multocida from the cloaca.

 

Discussion

Studies of complement activity to P. multocida have been carried out by inoculation of a suspension of viable organisms into serum and by determination of surviving organisms, either by counting viable cells (Morishita et al., 1990; Diallo & Frost, 2000) or by measuring changes in the optical density (Lee et al., 1988a,b). Classification of strains into serum­sensitive and serum-resistant seems to be arbitrary, because of variations in detection techniques, inoculation dose and incubation time used by different workers (Lee et al., 1988b; Morishita et al., 1990; Diallo & Frost, 2000). Lack of a standardized technique for estimating serum activity of P. multocida makes meaningful comparison between studies difficult. However, the findings obtained from both viable cell counts and OD changes have been successfully correlated with virulence in poultry (Lee et al., 1988a,b; Morishita et al., 1990). Neither method indicates the actual amount of complement deposited on the bacterium. How this affects the classification of strains into serum­sensitive and serum-resistant is not known, but failure to correlate serum activity with virulence has been reported (Morishita et al., 1990; Diallo & Frost, 2000). Direct detection of deposited complement components C6 and C9 on the bacterial surface by immunofluorescence (Kraiczy et al. 2000) was demonstrated to be useful in determining the activity of human serum on Borrelia burgdorferi. Develop­ment of similar complement detection techniques may help to improve studies of P. multocida serum resistance in different animal species.

 

 

Table 3. Mortality and carrier status of chickens experimentally infected with different strains of P. multocida ssp. multocida

 

 

 

This study has demonstrated for the first time that turkey serum was less inhibitory to a wide range of P. multocida strains than chicken, duck and pig sera (Table 1). Sixty-seven out of 80 strains of P. multocida (including all three subspecies) had higher OD values than the avirulent serum-sensitive CU vaccine strain (Hansen & Hirsh, 1989) in the turkey serum (Table 1). In chicken, duck and pig sera, only 10, 15 and 13 P. multocida strains, respectively, had OD values higher than the CU vaccine strain. Earlier studies showed that chicken serum was not inhibitory to P. multocida while cattle, horse, swine and rabbit sera had various degrees of inhibition (Ryu, 1959). Findings based on a single strain by Diallo & Frost (2000) showed that a P. multocida strain sensitive to chicken serum was resistant in turkey, sheep, bovine and rabbit serum. Different assay techniques and the limited number of strains employed in those studies do not allow safe comparison with the present results. However, the results indicate that sera from differ­ent animals vary in their reactions to P. multocida, and it can be concluded that the higher susceptibil­ity of turkeys to fowl cholera correlates with their lower serum activity against P. multocida strains. As P. multocida has been demonstrated to bind iron-chelating proteins such as transferrin (Ogun­nariwo et al., 1991), differences in the amounts of iron acquired from different species sera should be investigated to understand the role iron acquisition in growth of P. multocida in animal sera.

The present study has shown that three out of five (60%) P. multocida strains obtained from fowl cholera outbreaks were serum resistant in all bird sera, while all nine avian carrier strains were serum sensitive. Separate studies with outbreak strains found that 60% of the strains were resistant to turkey serum (Lee et al., 1988a) and 88% resistant to chicken serum (Diallo & Frost, 2000). It can be postulated that serum-resistant strains are more prevalent among fowl cholera outbreak strains, for reasons yet to be determined. Serial passage of strains in serum and live birds and comparison of a wider collection of avirulent and virulent strains is required to reach a sound conclusion on the effect of host on serum resistance to P. multocida. Increase in serum resistance subsequent to serial passage in human serum has been demonstrated in Neisseria gonorrhoea strains (Ram et al., 1999). This effect has been demonstrated due to sialic acid modification of gonococcal lipo-oligosaccharide, but a similar phenomenon has not been shown to occur in P. multocida. However, a change in the virulence of P. multocida through a serial intra­venous passage in turkeys has been reported (Matsumoto & Strain, 1993). It is possible that, through repeated transmissions among birds, a strain may adapt to serum components and grow better than newly introduced strains. However, this cannot fully explain the serum resistance of P. multocida to avian sera as the present results have shown that resistant strains are present among non­avian isolates and P. dagmatis strains. This suggests the involvement of other determinants of resistance to P. multocida to serum bactericidal activity.

Early findings by Griffiths (1974) suggested that RNA is the target for antibody-mediated comple­ment activity to P. multocida, but the role of RNA in non-antibody-mediated complement killing of serum-sensitive and serum-resistant strains has not been determined. Subsequently, attempts were made to transform P. multocida serum-sensitive strains to serum-resistant strains by cloning with plasmids from serum-resistant strains (Lee & Woo­ley, 1995). However, the transformants obtained were of intermediate serum resistance compared with a serum-resistant field isolate. This indicated involvement of other factors in serum resistance of P. multocida. Hansen & Hirsh (1989) showed that the hyaluronic acid capsule was responsible for serum resistance among capsular type A strains. Subsequent investigations by Diallo & Frost (2000) showed that seven strains remained serum resistant while three remained serum sensitive after treat­ment with hyaluronidase. In the present study, the protective effect of the capsule to serum comple­ment activity was not confirmed, which underlines the fact that the serum resistance of P. multocida is multifactorial.

Although the outbreak clone P-40605, which is serum resistant, caused more severe lesions in experimentally infected chickens, serum resistance cannot be concluded to be the only determinant of virulence of P. multocida. Lesions caused by the serum-sensitive strain KC 14Hpg were more severe than the serum-resistant strain MC 6BA, as well as the sensitive strain Mamo 2. Strain MC 6BA was not recovered from trachea of the chickens 24 h after infection, whereas the remaining strains were re-isolated (Table 3). However, it was only the outbreak clone that remained in the trachea for up to 14 days, which indicated that the clone was able to colonize in the trachea mucosa for a long time. These findings indicate that serum resistance cou­pled with the ability to colonize the trachea may influence virulence of P. multocida strains to chickens. Glorioso et al. (1982) demonstrated that the presence of adhesion factors on the cell surface were responsible for colonization of the pharyngeal mucosa by P. multocida strains that cause respira­tory tract infections in rabbits. Further investiga­tions on the combined influence of adhesion factors and serum resistance might increase the under­standing of virulence of P. multocida.

In conclusion, this study has shown that resistance of P. multocida to serum activity occurs among strains from different hosts. Turkey serum was shown to be less inhibitory than other sera investigated. Although the serum-resistant strains are not clonal, strains with the same genotype have the same serum activity, suggesting that the trait is heterogeneous within the species P. multocida. The findings also underline that P. multocida serum resistance is multifactorial.

 

 

Acknowledgements

The Danish International Agency for Development (DANIDA) is thanked for financing the project. The authors are grateful to Vibeke Sorensen of SVS Copenhagen for provision of specific pathogen free pig serum. The assistance of Kamille Petersen, Paul Mbuthia, and Dennis Byarubaga in the experi­mental infection is highly appreciated.

 

 

References

Christensen, J.P., Dietz, H.H. & Bisgaard, M. (1998). Phenotypic and genotypic characters of isolates of Pasteurella multocida obtained from two outbreaks of avian cholera in avifauna in Denmark. Avian Pathology, 27, 373–381.

Davies, R.L. (1991). Virulence and serum-resistance in different clonal groups and serotypes of Yersinia ruckeri. Veterinary Microbiology, 29, 289–297.

Diallo, I.S. & Frost, A.J. (2000). Survival of avian strains of Pasteurella multocida in chicken serum. Veterinary Microbiology, 72, 153–161.

Ellis, M.G., Arp, L.H. & Lamont, S.J. (1988). Serum resistance and virulence of Escherichia coli isolated from turkeys. American Journal of Veterinary Research, 49, 2034–2037.

Glorioso, J.C., Jones, G.W., Rush, H.G., Pentler, L.J., Darif, C.A. & Coward, J.E. (1982). Adhesion of type A Pasteurella multocida and its possible role in rabbit respiratory tract infections. Infection and Immunity, 35, 1103–1109.

Griffiths, F. (1974). Metabolically controlled killing of Pasteurella septica by antibody and complement. Biochimica et Biophysica Acta, 362, 598–602.

Hansen, L.M. & Hirsh, D.C. (1989). Serum resistance is correlated with encapsulation of avian strains of Pasteurella multocida. Veterinary Microbiology, 21, 177–184.

Jasmin, A.M. (1945). An improved staining method for demonstrating bacterial capsules, with particular reference to Pasteurella. Journal of Bacteriology, 50, 361–363.

Kraiczy, J., Hunfeld, K., Breitner-Ruddock, S., Wurzner, R., Acker, G. & Brade, V. (2000). Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi. Immuno­biology, 201, 406–419.

Lee, M.D. & Wooley, R.E. (1995). The effect of plasmid acquisition on potential virulence attributes of Pasteurella multocida. Avian Diseases, 39, 451–457.

Lee, M.D., Wooley, R.E., Glisson, J.R. & Brown, J. (1988a). Comparison of Pasteurella multocida serotype 3,4 isolates from turkeys with fowl cholera. Avian Diseases, 32, 501–508.

Lee, M.D., Brown, J., Wooley, R.E. & Glisson, J.R. (1988b). The relationship of pathogenicity to the growth of Pasteurella multocida serotype 3,4 isolates in normal turkey plasma. Avian Diseases, 32, 509–512.

Matsumoto, M. & Strain, J.G. (1993). Pathogenicity of Pasteurella multocida: its variable nature demonstrated by in vivo passages. Avian Diseases, 37, 781–785.

Matsumoto, M., Strain, J.G. & Engel, H.N. (1991). The fate of Pasteurella multocida after intratracheal inoculation in turkeys. Poultry Science, 70, 2259–2266.

Morishita, T.Y., Snipes, K.P. & Carpenter, T.E. (1990). Serum resistance as an indicator of virulence of Pasteurella multocida for turkeys. Avian Diseases, 34, 888–892.

Muhairwa, A.P., Christensen, J.P. & Bisgaard, M. (2000). Investiga­tions on the carrier rate of Pasteurella multocida in healthy commercial poultry flocks and flocks affected by fowl cholera. Avian Pathology, 29, 133–142.

Muhairwa, A.P., Mtambo, M.M.A., Christensen, J.P. & Bisgaard, M. (2001a). Occurrence of Pasteurella multocida and related species in free ranging poultry and their animal contacts in Tanzania. Veterinary Microbiology, 78, 139–153.

Muhairwa, A.P., Christensen, J.P. & Bisgaard, M. (2001b). Relation­ships among Pasteurellaceae isolated from free ranging poultry and their animal contacts as determined by quantitative phenotyping and by ribotyping. Veterinary Microbiology, 78, 119–138.

Ogunnariwo, J.A., Alcantara, J. & Schryvers, A.B. (1991). Evidence for non-siderophore-mediated acquisition of transferrin-bound iron by Pasteurella multocida. Microbial Pathogenesis, 11, 47–56.

Petersen, K.D., Christensen, J.P., Permin, A.P., Bisgaard, M. (2001). Virulence of Pasteurella multocida ssp. multocida isolated from outbreaks of fowl cholera in wild birds for domestic poultry and game birds. Avian Pathology, 30, 27–31.

Poermadjaja, B. & Frost, A. (2000). Phagocytic uptake and killing of virulent and avirulent strains of Pasteurella multocida of capsular serotype A by chicken macrophages. Veterinary Microbiology, 72, 163–171.

Ram, S., Mackinnon, F.G., Gulati, S., McQuillen, D.P., Vogel, U., Guttormsen, H.-K., Wetzler, L.M., Oppermann, M., Pangburn, M.K. & Rice, P.A. (1999). The contrasting mechanisms of serum resistance of Neisseria gonorhhoea and group B Neisseria meningiti­dis. Molecular Immunology, 36, 915–928.

Rimler R.B. & Glisson J.R. (1997). Fowl Cholera. In B.W. Calnek, H.J. Barnes, C.W. Beard, L.R. McDougald & Y.M. Saif (Eds.), Poultry Diseases (pp. 143–159). London: Mosby-Wolfe.

Ryu, E. (1959). Studies on Pasteurella multocida I. Inhibitory action of blood on the growth of Pasteurella multocida. The Japanese Journal of Veterinary Science, 21, 97–102.

Taylor, P. (1983). Bactericidal and bacteriolytic activity of serum against Gram-negative bacteria. Microbiological Reviews, 47, 46–83.

 

(order Full Text from publisher)

 

 

   Scientific Publications - Work Done by Microbiology Reader Bioscreen C

Agricultural Microbiology
Anaerobic Microbiology
Antimicrobial Susceptibility
Artificial Atmosphere
Bioassay of Antibiotics
Biofilm Microbiology
Bioreactor Technology
Biotechnology
Cell Biology
Clinical Microbiology
Environmental Microbiology
Experiments with Yeast
Fermentation
Food Microbiology
Functional Genomics
Gene Technology
Growth Media Development
Growth Rate and Lag Time
Industrial Microbiology
Medical/Pharmaceutical Field
Microbiological Assay
Microbiological Research
Microbiology of Cosmetics

go to a specific theme...

Military Microbiology
Molecular Microbiology
Mutagenicity and Genotoxicity
Oral Microbiology
Patents
Postantibiotic Studies
Soil Microbiology
Spore Microbiology
Veterinary Microbiology
Waste/Wastewater Treatment
Water Microbiology
Wine Microbiology

 


 

© 2005 Transgalactic Ltd (manufacturer of Bioscreen C software) | Privacy Statement | P.O. Box 1393, 00101 Helsinki, Finland, phone: +358 9 85172920, fax: +358 9 8749481, e-mail: microbiology@bionewsonline.com
 

 

 

Last modified: May 25, 2005